In a randomized, prospective pilot study, we compared awake blind orotracheal intubation using the intubating laryngeal mask airway (blind-ILM) with awake fibreoptic-guided orotracheal intubation using an Ovassapian airway (FOS-OA). Fifty-four patients (ASA 1 to 3, aged 18 to 85 years) requiring awake intubation for elective surgery were randomly allocated by coin toss into two groups: 31 patients were intubated blindly through the ILM (blind-ILM) and 23 were intubated using fibreoptic guidance through the Ovassapian airway (FOS-OA). Sedation to a target clinical end-point (spontaneous eye-closing, but responsive to verbal command) was obtained with fentanyl/midazolam and a cricothyroid puncture was performed with 3 ml lignocaine 4%. The oropharynx was then topicalized until tolerance of a Guedel airway was achieved. The number of failed attempts (maximum of three allowed), overall success rates, the time from insertion of the airway to capnographic (blind-ILM) or fibreoptic (FOS-OA) confirmation of intubation or until three failed attempts, and cardiovascular responses before and during intubation, were recorded. The first time () intubation success rates were similar. The mean±SD time to intubation was shorter for the blind-ILM group (104±65 vs 158±115 sec, P=0.05 ). There were no clinically significant differences in blood pressure or heart rate between groups. Compared with baseline values, there was no cardiovascular response to intubation in either group. We conclude that the blind-ILM and FOS-OA techniques have similar success rates and cardiovascular responses, but intubation is slightly quicker with the blind-ILM technique.
The technique of choice for awake tracheal intubation is with fibreoptic guidance 1 , but to our knowledge there are no comparative studies with other techniques. The intubating laryngeal mask airway (ILM) has been used for awake intubation when fibreoptic guidance has failed 2 or as a first-line technique [3] [4] [5] . In a pilot study in awake patients, we compared blind ILM-guided orotracheal intubation with fibreoptic-guided orotracheal intubation using an Ovassapian airway (FOS-OA).
METHODS
With Ethics Committee approval and written informed consent, 54 patients (ASA 1 to 3, aged 18 to 85 years) requiring awake intubation (cervical spine disease, aspiration risk, predicted or known difficult airway) for major elective surgery (orthopaedic, general, urological and gynaecological) were randomly assigned (by coin toss) to ILM-guided blind orotracheal intubation (blind-ILM group) or fibreoptic-guided orotracheal intubation using an Ovassapian airway (FOS-OA group). Exclusion criteria were cardiorespiratory disease, mouthopening less than 2.5 cm or upper airway pathology. Patients were sedated with midazolam 0 to 5 mg and/or fentanyl 0 to 250 µg until they spontaneously closed their eyes, but were still able to follow verbal commands. A cricothyroid puncture was performed with 3 ml lignocaine 4% and the oropharynx was topicalized with 10% lignocaine spray (both without adrenaline) up to the maximum recommended lignocaine dose or until the patient could tolerate a Guedel oral airway. Airway device insertion and intubation were attempted without additional sedation at least two minutes after topical anaesthesia was applied. Airway management was performed by four anaesthetists who had performed each technique at least 10 times prior to the study.
In the blind-ILM group, the ILM (size 4, females; size 5, males) was inserted with head and neck in the neutral position using a single-handed rotational technique. In patients with cervical spine disease, the head and neck were as close to the neutral position as tolerated. The cuff was inflated with air up to the maximum recommended volume (size 4, 30 ml; size 5, 40 ml) until an airtight seal was obtained and this position was maintained for intubation by holding the handle firmly. If necessary, the ILM position was adjusted until a clear airway was obtained. An 8 mm lubricated straight silicone tracheal tube with a midline bevel (Euromedical Industries, Penang, Malaysia) was placed in the ILM tube and advanced to 1 cm beyond the epiglottic elevator bar. Intubation was attempted by gently advancing the tube. If any tactile resistance was felt, the tracheal tube was withdrawn and the following adjusting manoeuvres were applied in sequence before the tracheal tube was advanced again: 1. pulling the handle back towards the intubator; 2. withdrawal of the ILM by 5 cm followed by reinsertion. If no resistance was felt after the tube was advanced 8 cm, the cuff was inflated.
In the FOS-OA group, the OA was inserted and fibreoptic intubation was attempted with the headneck in the neutral position using an 8 mm lubricated PVC tube (Hi-Lo, Mallinckrodt Medical, Athlone, Ireland) preloaded on a fibrescope (Olympus LF2, Olympus America, Melville, NY). For the blind-ILM group, correct placement was confirmed by capnography and oesophageal intubation was diagnosed if there was no capnograph trace. For the FOS-OA group, the fibreoptic scope was used to diagnose correct placement and oesophageal intubation. Three attempts were allowed before intubation was considered a failure. A failed attempt was defined as failed insertion or removal of the ILM/Ovassapian airway from the mouth, or removal of the tracheal tube from the ILM/Ovassapian airway, or oesophageal intubation. At the end of the procedure the lips, tongue and oral cavity were inspected for evidence of trauma (cuts, abrasions or blood). Patients were questioned about their experience on the first postoperative day.
An unblinded independent observer collected the following data: the time from ILM/OA insertion to confirmation of intubation (intubation time) or after three failed attempts; the number of failed attempts and overall success rate. Mean blood pressure (BP) and heart rate (HR) were measured one minute before insertion of the ILM/Ovassapian airway (baseline) and at one-minute intervals thereafter until intubation was successful or failed (intubation). The intubation mean BP and HR were the average of values during the intubation time. Any episodes of hypoxia (SpO 2 <90%) were noted. Statistical analysis was with Student's t-test, Chi squared test and the Fisher's exact test. Significant was taken as P<0.05.
RESULTS
Demographic, Mallampati score, sedation, intubation and cardiovascular data are presented in Table 1 . There were no demographic differences and the dose of sedatives was similar between groups. Guedel airway insertion was possible in all patients before the maximum lignocaine dose was reached. The FOS-OA group failure resulted from repeated inability to manipulate the tracheal tube through the cords over the fibreoptic scope. Two of the blind-ILM group failures were from failed insertion secondary to intolerance of the ILM, one failure was from repeated oesophageal intubation and two were from a combination of intolerance and oesophageal intubation. There were no clinically significant differences in BP or HR between groups. Compared with baseline values, there was no cardiovascular response to awake intubation in either group and hypoxia did not occur. No airway injuries were noted and no patient remembered the procedure at follow-up.
DISCUSSION
We found that the success rates for blind orotracheal intubation using the ILM and fibrescopeguided orotracheal intubation using the Ovassapian airway were similar, but that intubation was slightly quicker with the ILM. Although the magnitude of the difference in intubation time was only 54 s, this could be clinically important for patients with compromised respiratory or neurological function. Our success rates were lower than Shung et al 5 who reported 15/15 successful awake intubations with the blind technique. Our success rate for the awake FOS-OA technique was similar to other researchers 6 .
The two main reasons for failure in the blind-ILM group were intolerance to the ILM and oesophageal intubation. Intolerance to the ILM may be related to its bulk and/or to high pressures exerted against the pharyngeal mucosa 7 . Tolerance may have been improved by using larger doses of sedation or local anaesthesia. Repeated oesophageal intubation might have been avoided if a fibreoptic-guided ILM technique had been used. Although there are no studies demonstrating a lower incidence of oesophageal intubation with the fibreoptic-guided ILM technique, Cros et al 8 showed that the fibreoptic technique often succeeded where the blind technique failed. Other than for teaching purposes, we consider that a fibreoptic-guided ILM technique is preferable to a blind ILM technique whenever the equipment is available.
Another option for improving intubation success rates might have been to use a smaller tracheal tube. We recommend that a capnograph is available to detect oesophageal intubation whenever the ILM is being used for blind intubation.
We found no cardiovascular response for either technique during intubation compared with baseline values. This might reflect the effectiveness of sedation and topicalization or that the baseline values were still raised following the cricothyroid puncture and topicalization. Unfortunately, we did not record HR and BP before cricothyroid puncture and topicalization. The higher HR during intubation in the blind-ILM group probably reflects a spuriously higher baseline value. Joo et al 9 showed that the cardiovascular response to ILM-guided intubation was lower than laryngoscope-guided intubation in anaesthetized patients. Interestingly, the cardiovascular response to awake fibreoptic intubation is lower than laryngoscope-guided intubation in anaesthetized patients 10 .
We conclude that the blind-ILM and FOS-OA techniques have similar success rates and cardiovascular responses, but intubation is slightly quicker with the blind-ILM technique. 
